Net profit surged 52.8% YoY, reaching ₹125.1 Crore, compared to ₹81.9 Crore in the same quarter last year.
The European Directorate for the Quality of Medicines & Healthcare (EDQM) gave Shilpa Pharma Lifesciences, the company's subsidiary, the Certificate of Suitability (CEP) for Nifedipine.
The IPO is an offer-for-sale by the promoters, selling shares held in the company worth ₹841 Crore for sale through the OFS, said Pinky Agarwal.
INEOS Acetyls is the world's leading producer of acetic acid, whereas GNFC is the only current manufacturer in India.
With a minimum application of 138 shares and an investment of Rs 14,904, retail investors can take part.
Asian markets declined on Thursday, tracking Wall Street’s cautious sentiment. Nvidia’s weaker revenue forecast added to the market’s concerns.
The net profit for the cables and wires manufacturing firm climbed by 7.7% from the same quarter previous year to ₹268.2 Crore.
SEBI issued an observation letter for the IPO on Nov 13,2024, thus enabling the company to file for listing within one year.
The demand for energy storage solutions in India is growing. Battery stocks provide an opportunity to benefit from this trend.
Here are some of the stocks that may see significant price movement today: UPL, Tata Power, JSW Steel, Dr Reddy’s, etc.

IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.